SecSonar.com

iBio, Inc. (IBIO)

iBio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

iBio, Inc. (IBIO) is a Biotechnology company based in US with a market capitalization of $30.2M. Free cash flow was negative at -$15.3M. This page tracks IBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 16 employees · IPO Aug 19, 2008

Valuation

Valuation & price

$1.47 · as of May 17, 2026 · -52.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.07$1.83$0.59Jul 25Dec 25Jul 26Jul 7, 25$0.78Jul 9, 25$0.84Jul 11, 25$0.81Jul 15, 25$0.72Jul 17, 25$0.73Jul 21, 25$0.73Jul 23, 25$0.76Jul 25, 25$0.73Jul 29, 25$0.69Jul 31, 25$0.68Aug 4, 25$0.63Aug 6, 25$0.59Aug 11, 25$0.59Aug 13, 25$0.73Aug 15, 25$0.74Aug 19, 25$0.73Aug 21, 25$0.78Aug 25, 25$0.85Aug 27, 25$0.81Aug 29, 25$0.82Sep 3, 25$0.86Sep 5, 25$0.83Sep 9, 25$0.83Sep 11, 25$0.96Sep 16, 25$0.86Sep 18, 25$0.87Sep 22, 25$0.81Sep 24, 25$0.83Sep 26, 25$0.81Sep 30, 25$0.83Oct 2, 25$0.83Oct 6, 25$0.85Oct 8, 25$0.87Oct 10, 25$0.79Oct 14, 25$0.80Oct 16, 25$0.85Oct 21, 25$1.11Oct 23, 25$1.27Oct 27, 25$1.28Oct 29, 25$1.54Oct 31, 25$1.60Nov 4, 25$1.53Nov 6, 25$1.39Nov 10, 25$1.29Nov 12, 25$1.25Nov 14, 25$1.16Nov 18, 25$1.21Nov 20, 25$1.00Nov 25, 25$1.17Nov 28, 25$1.23Dec 2, 25$1.07Dec 4, 25$1.28Dec 8, 25$1.67Dec 10, 25$2.81Dec 12, 25$1.94Dec 16, 25$2.06Dec 18, 25$1.88Dec 22, 25$2.01Dec 24, 25$1.87Dec 29, 25$1.85Jan 2, 26$2.02Jan 6, 26$2.06Jan 8, 26$2.35Jan 12, 26$2.70Jan 14, 26$2.49Jan 16, 26$2.20Jan 21, 26$2.24Jan 23, 26$2.25Jan 27, 26$2.28Jan 29, 26$2.15Feb 2, 26$2.30Feb 4, 26$2.20Feb 9, 26$2.41Feb 11, 26$2.21Feb 13, 26$2.22Feb 18, 26$2.33Feb 20, 26$2.38Feb 24, 26$2.47Feb 26, 26$3.07Mar 2, 26$2.69Mar 4, 26$2.83Mar 6, 26$2.61Mar 10, 26$2.38Mar 12, 26$2.49Mar 17, 26$2.46Mar 19, 26$2.10Mar 23, 26$2.21Mar 25, 26$2.18Mar 27, 26$1.76Mar 31, 26$1.90Apr 2, 26$1.98Apr 7, 26$2.11Apr 9, 26$2.20Apr 13, 26$2.20Apr 15, 26$2.10Apr 17, 26$2.06Apr 22, 26$1.92Apr 24, 26$1.68Apr 28, 26$1.63Apr 30, 26$1.69May 4, 26$1.58May 6, 26$1.77May 8, 26$1.71May 12, 26$1.61May 14, 26$1.56May 18, 26$1.42May 20, 26$1.70May 22, 26$1.84May 28, 26$1.93Jun 1, 26$1.89Jun 3, 26$1.84Jun 5, 26$1.82Jun 9, 26$1.70Jun 11, 26$1.67Jun 15, 26$1.65Jun 17, 26$1.60Jun 22, 26$1.74Jun 24, 26$1.62Jun 26, 26$1.67Jul 2, 26$1.68
$0.5752-week range$3.07
Loading valuation history…

Fundamentals

Key fundamentals

$30.2M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$15.3M

Free cash flow (USD)

-$5.1M

Net debt

Net cash position

174.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$948.0KFY 2017$394.0KFY 2018$444.0KFY 2019$2.0MFY 2020$1.6MFY 2021$2.4MFY 2022$1.9MFY 2023$0.00FY 2024$225.0KFY 2025$400.0K
$948K$400K

Free cash flow by year

2016 → 2025

FY 2016$-8.1MFY 2017$-14.8MFY 2018$-14.6MFY 2019$-15.0MFY 2020$-14.5MFY 2021$-35.2MFY 2022$-45.1MFY 2023$-36.2MFY 2024$-18.8MFY 2025$-15.3M
-$8.1M-$15.3M

Gross margin by year

2021 → 2025

FY 202138.3%FY 2022-101.2%FY 2024100.0%FY 2025100.0%
38.3%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPreclinical Data AnnouncementJul 1, 2026Filing
  • 8-K eventClinical Trial InitiationMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventDirector AppointmentMay 8, 2026Filing
  • 8-K eventWarrant Expiration UpdateApr 17, 2026Filing
  • 8-K eventClinical Trial InitiationApr 8, 2026Filing

Questions

Frequently asked questions

What is iBio, Inc.'s market cap?

iBio, Inc. (IBIO) has a market capitalization of $30.2M.

What is IBIO's P/E ratio?

A meaningful P/E ratio is not available for IBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IBIO's price-to-book (P/B) ratio?

IBIO trades at 2.03 times book value per share.

Are insiders buying IBIO stock?

SEC Form 4 filings show no open-market insider buys at iBio, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

OTLK

Outlook Therapeutics, Inc.

$30M

TVRD

Tvardi Therapeutics, Inc.

$31.4M

LSTA

Lisata Therapeutics, Inc.

$28.8M

IGC

IGC Pharma, Inc.

$28.7M

BRNS

Barinthus Biotherapeutics plc

$27.9M

DYAI

Dyadic International, Inc.

$27.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.